| P2093 | author name string | Xiao-xing Wang | |
| | Hui-min Yan | |
| | Zhuo-wei Hu | |
| | Xiao-xi Lv | |
| | Zi-yan Wang | |
| | Han-zhi Liu | |
| | Jia-ping Wang | |
| | Xiao-ming Fu | |
| P2860 | cites work | Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation | Q77753940 |
| | Inflammation and atherosclerosis | Q80015206 |
| | Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice | Q80805032 |
| | Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome | Q80819961 |
| | Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment | Q83089214 |
| | TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production | Q85005541 |
| | Toll-like receptor signalling | Q24570126 |
| | Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings | Q27300289 |
| | Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data | Q28242645 |
| | TLR signaling | Q28291637 |
| | Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress | Q29615495 |
| | Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE | Q29620722 |
| | Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP. | Q30488194 |
| | Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events | Q33318184 |
| | Modulation of atherosclerosis in mice by Toll-like receptor 2 | Q34063165 |
| | Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice. | Q34342389 |
| | Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress | Q34346809 |
| | TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. | Q35041384 |
| | Endogenous ligands of Toll-like receptors | Q35792678 |
| | Toll-like receptor signaling and atherosclerosis | Q36433507 |
| | Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. | Q36459911 |
| | Multiple roles of Toll-like receptor signaling in atherosclerosis | Q36589015 |
| | Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists | Q36811131 |
| | Mouse models for atherosclerosis and pharmaceutical modifiers. | Q36836487 |
| | Innate immunity, macrophage activation, and atherosclerosis | Q36938635 |
| | Molecular mechanisms of plaque instability | Q36947974 |
| | The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis | Q37065920 |
| | Progression and disruption of advanced atherosclerotic plaques in murine models | Q37108304 |
| | Immune and inflammatory mechanisms of atherosclerosis (*) | Q37325024 |
| | Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress | Q37401270 |
| | Endoplasmic reticulum stress increases the expression and function of toll-like receptor-2 in epithelial cells. | Q39646441 |
| | Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. | Q40255422 |
| | Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. | Q41862930 |
| | Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis | Q42641324 |
| | The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. | Q42961940 |
| | Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development | Q46380675 |
| | Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice | Q47320668 |
| | Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. | Q53606830 |
| | Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse | Q73295343 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1025-1035 | |
| P577 | publication date | 2013-07-15 | |
| P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
| P1476 | title | Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice | |
| P478 | volume | 34 | |